Cargando…
SC75741, A Novel c-Abl Inhibitor, Promotes the Clearance of TDP25 Aggregates via ATG5-Dependent Autophagy Pathway
Abnormal accumulation of TDP43-related mutant proteins in the cytoplasm causes amyotrophic lateral sclerosis (ALS). Herein, unbiased drug screening approaches showed that SC75741, a multi-target inhibitor, inhibited inflammation-induced aggregation by inhibiting NF-κB and also degraded already aggre...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586708/ https://www.ncbi.nlm.nih.gov/pubmed/34776962 http://dx.doi.org/10.3389/fphar.2021.741219 |
_version_ | 1784597948349284352 |
---|---|
author | Zhou, Dongheng Yan, Huanhuan Yang, Shuying Zhang, Yuhong Xu, Xiaoyan Cen, Xufeng Lei, Kai Xia, Hongguang |
author_facet | Zhou, Dongheng Yan, Huanhuan Yang, Shuying Zhang, Yuhong Xu, Xiaoyan Cen, Xufeng Lei, Kai Xia, Hongguang |
author_sort | Zhou, Dongheng |
collection | PubMed |
description | Abnormal accumulation of TDP43-related mutant proteins in the cytoplasm causes amyotrophic lateral sclerosis (ALS). Herein, unbiased drug screening approaches showed that SC75741, a multi-target inhibitor, inhibited inflammation-induced aggregation by inhibiting NF-κB and also degraded already aggregated proteins by inhibiting c-Abl mediated autophagy-lysosomal pathway. We delineate the mechanism that SC75741 could markedly enhance TFEB nuclear translocation by an mTORC1-independent TFEB regulatory pathway. In addition, SC75741 enhanced the interaction between p62 with TDP25 and LC3C, thus promoting TDP25 degradation. Taken together, these findings show that SC75741 has beneficial neuroprotective effects in ALS. Our study elucidates that dual-targeted inhibition of c-Abl and NF-κB may be a potential treatment for TDP43 proteinopathies and ALS. |
format | Online Article Text |
id | pubmed-8586708 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-85867082021-11-13 SC75741, A Novel c-Abl Inhibitor, Promotes the Clearance of TDP25 Aggregates via ATG5-Dependent Autophagy Pathway Zhou, Dongheng Yan, Huanhuan Yang, Shuying Zhang, Yuhong Xu, Xiaoyan Cen, Xufeng Lei, Kai Xia, Hongguang Front Pharmacol Pharmacology Abnormal accumulation of TDP43-related mutant proteins in the cytoplasm causes amyotrophic lateral sclerosis (ALS). Herein, unbiased drug screening approaches showed that SC75741, a multi-target inhibitor, inhibited inflammation-induced aggregation by inhibiting NF-κB and also degraded already aggregated proteins by inhibiting c-Abl mediated autophagy-lysosomal pathway. We delineate the mechanism that SC75741 could markedly enhance TFEB nuclear translocation by an mTORC1-independent TFEB regulatory pathway. In addition, SC75741 enhanced the interaction between p62 with TDP25 and LC3C, thus promoting TDP25 degradation. Taken together, these findings show that SC75741 has beneficial neuroprotective effects in ALS. Our study elucidates that dual-targeted inhibition of c-Abl and NF-κB may be a potential treatment for TDP43 proteinopathies and ALS. Frontiers Media S.A. 2021-10-29 /pmc/articles/PMC8586708/ /pubmed/34776962 http://dx.doi.org/10.3389/fphar.2021.741219 Text en Copyright © 2021 Zhou, Yan, Yang, Zhang, Xu, Cen, Lei and Xia. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Zhou, Dongheng Yan, Huanhuan Yang, Shuying Zhang, Yuhong Xu, Xiaoyan Cen, Xufeng Lei, Kai Xia, Hongguang SC75741, A Novel c-Abl Inhibitor, Promotes the Clearance of TDP25 Aggregates via ATG5-Dependent Autophagy Pathway |
title | SC75741, A Novel c-Abl Inhibitor, Promotes the Clearance of TDP25 Aggregates via ATG5-Dependent Autophagy Pathway |
title_full | SC75741, A Novel c-Abl Inhibitor, Promotes the Clearance of TDP25 Aggregates via ATG5-Dependent Autophagy Pathway |
title_fullStr | SC75741, A Novel c-Abl Inhibitor, Promotes the Clearance of TDP25 Aggregates via ATG5-Dependent Autophagy Pathway |
title_full_unstemmed | SC75741, A Novel c-Abl Inhibitor, Promotes the Clearance of TDP25 Aggregates via ATG5-Dependent Autophagy Pathway |
title_short | SC75741, A Novel c-Abl Inhibitor, Promotes the Clearance of TDP25 Aggregates via ATG5-Dependent Autophagy Pathway |
title_sort | sc75741, a novel c-abl inhibitor, promotes the clearance of tdp25 aggregates via atg5-dependent autophagy pathway |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586708/ https://www.ncbi.nlm.nih.gov/pubmed/34776962 http://dx.doi.org/10.3389/fphar.2021.741219 |
work_keys_str_mv | AT zhoudongheng sc75741anovelcablinhibitorpromotestheclearanceoftdp25aggregatesviaatg5dependentautophagypathway AT yanhuanhuan sc75741anovelcablinhibitorpromotestheclearanceoftdp25aggregatesviaatg5dependentautophagypathway AT yangshuying sc75741anovelcablinhibitorpromotestheclearanceoftdp25aggregatesviaatg5dependentautophagypathway AT zhangyuhong sc75741anovelcablinhibitorpromotestheclearanceoftdp25aggregatesviaatg5dependentautophagypathway AT xuxiaoyan sc75741anovelcablinhibitorpromotestheclearanceoftdp25aggregatesviaatg5dependentautophagypathway AT cenxufeng sc75741anovelcablinhibitorpromotestheclearanceoftdp25aggregatesviaatg5dependentautophagypathway AT leikai sc75741anovelcablinhibitorpromotestheclearanceoftdp25aggregatesviaatg5dependentautophagypathway AT xiahongguang sc75741anovelcablinhibitorpromotestheclearanceoftdp25aggregatesviaatg5dependentautophagypathway |